| Host: | Mouse |
| Applications: | ELISA |
| Reactivity: | Human |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Mouse monoclonal antibody anti-PINP is suitable for use in ELISA research applications. |
| Clonality : | Monoclonal |
| Clone ID : | 11501 |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Formulation: | 50 mM Na-citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Purification: | Greater than 95% purity |
| Concentration: | 5.0 mg/ml (+/-10 %) |
| Storage Instruction: | Unspecified, storage at 2–8°C. Temperature analysis:-70 °C, 21 days Not Determined (N/D)-20 °C, 14 days OK +4 °C, 14 days OK +35 °C, 14 days OK +45 °C, 7 days OK. Shelf life stability testing at 2–8 °C in the product buffer. |
| Association Rate Constant: | 2.1 x 106 1/Ms |
| Determination Method: | SPR analysis (ProteOn XPR36) |
| Immunoreactivity: | 80–120 % compared to the reference sample in an FIA test |
| Immunogen: | Intact form of Human procollagen I N-terminal peptide |
| Background | Amino-terminal propeptide of type I procollagen (PINP) is released into blood circulation during bone formation. PINP is used as a bone turnover marker for the assessment of fracture risk and monitoring of osteoporosis treatment. PINP is recommended as reference bone formation marker by IOF and IFCC1. |
Information sourced from Uniprot.org